Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
Antiphospholipid syndrome is characterised by increased neutrophil extracellular trap formation (NETosis) and, consequently, increased thrombotic events. Here Ali et al. show that treatment with adenosine receptor agonists suppresses NETosis and venous thrombosis in mouse models of antiphospholipid...
Enregistré dans:
Auteurs principaux: | Ramadan A. Ali, Alex A. Gandhi, He Meng, Srilakshmi Yalavarthi, Andrew P. Vreede, Shanea K. Estes, Olivia R. Palmer, Paula L. Bockenstedt, David J. Pinsky, Joan M. Greve, Jose A. Diaz, Yogendra Kanthi, Jason S. Knight |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d8ca98b7f1d54784a2dbed7642ccb42a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia
par: José Perdomo, et autres
Publié: (2019) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
par: Katrien M.J. Devreese, et autres
Publié: (2021) -
SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
par: Nitin Kumar, et autres
Publié: (2021) -
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
par: Yu Zuo, et autres
Publié: (2021) -
Netosis in patients with systemic lupus erythematosus
par: V. V. Zhelezko, et autres
Publié: (2020)